A cell culture assay for compounds which inhibit hepatitis B virus replication
Identifieur interne : 001583 ( Istex/Corpus ); précédent : 001582; suivant : 001584A cell culture assay for compounds which inhibit hepatitis B virus replication
Auteurs : Brent E. Korba ; Gregory MilmanSource :
- Antiviral Research [ 0166-3542 ] ; 1991.
English descriptors
- Teeft :
- Analog, Antiviral, Antiviral activity, Assay, Carbocyclic analog, Cell culture assay, Cell cultures, Cell growth rates, Cell line, Chronic liver disease, Confluent cultures, Culture dishes, Culture media, Culture medium, Culture plates, Duck hepatitis, Effective agent, Episomal monomers, Extracellular, Genomic forms, Georgetown university, Hepatitis, Hepatocellular carcinoma, High levels, Infectious diseases, Inhibitory activities, Intracellular, Korba, Life technologies, Little activity, Liver disease, Lysis buffer, Methods section, Molecular virology, National institutes, Nitrocellulose membranes, Nucleoside, Nucleoside analog, Nucleoside analogs, Parent compound, Potent inhibitor, Pretreatment levels, Previous report, Relative amounts, Relevant animal models, Replication, Replication intermediates, Sensitivity cutoff, Size markers, Surface antigen, Test compounds, Tissue culture plates, Treatment period, Undetectable level, Viral, Viral hepatitis, Viral replication, Virus genome, Woodchuck, Woodchuck hepatitis virus.
Url:
DOI: 10.1016/0166-3542(91)90068-3
Links to Exploration step
ISTEX:C7121E5E27952F43A3367A0914BD4F71F313AC72Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>A cell culture assay for compounds which inhibit hepatitis B virus replication</title><author><name sortKey="Korba, Brent E" sort="Korba, Brent E" uniqKey="Korba B" first="Brent E." last="Korba">Brent E. Korba</name><affiliation><mods:affiliation>Georgetown University, Division of Molecular Virology and Immunology, Rockville, Maryland, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Milman, Gregory" sort="Milman, Gregory" uniqKey="Milman G" first="Gregory" last="Milman">Gregory Milman</name><affiliation><mods:affiliation>Department of Immunology and Infectious Diseases, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland, U.S.A.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C7121E5E27952F43A3367A0914BD4F71F313AC72</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1016/0166-3542(91)90068-3</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-KF2KH34H-W/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001583</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001583</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">A cell culture assay for compounds which inhibit hepatitis B virus replication</title><author><name sortKey="Korba, Brent E" sort="Korba, Brent E" uniqKey="Korba B" first="Brent E." last="Korba">Brent E. Korba</name><affiliation><mods:affiliation>Georgetown University, Division of Molecular Virology and Immunology, Rockville, Maryland, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Milman, Gregory" sort="Milman, Gregory" uniqKey="Milman G" first="Gregory" last="Milman">Gregory Milman</name><affiliation><mods:affiliation>Department of Immunology and Infectious Diseases, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland, U.S.A.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Antiviral Research</title><title level="j" type="abbrev">AVR</title><idno type="ISSN">0166-3542</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1991">1991</date><biblScope unit="volume">15</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="217">217</biblScope><biblScope unit="page" to="228">228</biblScope></imprint><idno type="ISSN">0166-3542</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0166-3542</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Analog</term><term>Antiviral</term><term>Antiviral activity</term><term>Assay</term><term>Carbocyclic analog</term><term>Cell culture assay</term><term>Cell cultures</term><term>Cell growth rates</term><term>Cell line</term><term>Chronic liver disease</term><term>Confluent cultures</term><term>Culture dishes</term><term>Culture media</term><term>Culture medium</term><term>Culture plates</term><term>Duck hepatitis</term><term>Effective agent</term><term>Episomal monomers</term><term>Extracellular</term><term>Genomic forms</term><term>Georgetown university</term><term>Hepatitis</term><term>Hepatocellular carcinoma</term><term>High levels</term><term>Infectious diseases</term><term>Inhibitory activities</term><term>Intracellular</term><term>Korba</term><term>Life technologies</term><term>Little activity</term><term>Liver disease</term><term>Lysis buffer</term><term>Methods section</term><term>Molecular virology</term><term>National institutes</term><term>Nitrocellulose membranes</term><term>Nucleoside</term><term>Nucleoside analog</term><term>Nucleoside analogs</term><term>Parent compound</term><term>Potent inhibitor</term><term>Pretreatment levels</term><term>Previous report</term><term>Relative amounts</term><term>Relevant animal models</term><term>Replication</term><term>Replication intermediates</term><term>Sensitivity cutoff</term><term>Size markers</term><term>Surface antigen</term><term>Test compounds</term><term>Tissue culture plates</term><term>Treatment period</term><term>Undetectable level</term><term>Viral</term><term>Viral hepatitis</term><term>Viral replication</term><term>Virus genome</term><term>Woodchuck</term><term>Woodchuck hepatitis virus</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><istex><corpusName>elsevier</corpusName><keywords><teeft><json:string>replication</json:string><json:string>viral</json:string><json:string>intracellular</json:string><json:string>korba</json:string><json:string>replication intermediates</json:string><json:string>analog</json:string><json:string>culture medium</json:string><json:string>nucleoside</json:string><json:string>antiviral</json:string><json:string>extracellular</json:string><json:string>woodchuck</json:string><json:string>hepatitis</json:string><json:string>assay</json:string><json:string>cell line</json:string><json:string>viral hepatitis</json:string><json:string>hepatocellular carcinoma</json:string><json:string>cell culture assay</json:string><json:string>culture media</json:string><json:string>liver disease</json:string><json:string>cell cultures</json:string><json:string>episomal monomers</json:string><json:string>viral replication</json:string><json:string>confluent cultures</json:string><json:string>methods section</json:string><json:string>undetectable level</json:string><json:string>sensitivity cutoff</json:string><json:string>georgetown university</json:string><json:string>culture plates</json:string><json:string>carbocyclic analog</json:string><json:string>potent inhibitor</json:string><json:string>test compounds</json:string><json:string>infectious diseases</json:string><json:string>antiviral activity</json:string><json:string>relevant animal models</json:string><json:string>tissue culture plates</json:string><json:string>nucleoside analog</json:string><json:string>parent compound</json:string><json:string>chronic liver disease</json:string><json:string>pretreatment levels</json:string><json:string>woodchuck hepatitis virus</json:string><json:string>culture dishes</json:string><json:string>treatment period</json:string><json:string>genomic forms</json:string><json:string>surface antigen</json:string><json:string>molecular virology</json:string><json:string>size markers</json:string><json:string>lysis buffer</json:string><json:string>effective agent</json:string><json:string>life technologies</json:string><json:string>nitrocellulose membranes</json:string><json:string>high levels</json:string><json:string>inhibitory activities</json:string><json:string>duck hepatitis</json:string><json:string>little activity</json:string><json:string>previous report</json:string><json:string>national institutes</json:string><json:string>virus genome</json:string><json:string>cell growth rates</json:string><json:string>nucleoside analogs</json:string><json:string>relative amounts</json:string></teeft></keywords><author><json:item><name>Brent E. Korba</name><affiliations><json:string>Georgetown University, Division of Molecular Virology and Immunology, Rockville, Maryland, U.S.A.</json:string></affiliations></json:item><json:item><name>Gregory Milman</name><affiliations><json:string>Department of Immunology and Infectious Diseases, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland, U.S.A.</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Cell culture assay</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Hepatitis B virus</value></json:item></subject><arkIstex>ark:/67375/6H6-KF2KH34H-W</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>Full-length article</json:string></originalGenre><qualityIndicators><score>6.202</score><pdfWordCount>4190</pdfWordCount><pdfCharCount>25747</pdfCharCount><pdfVersion>1.4</pdfVersion><pdfPageCount>12</pdfPageCount><pdfPageSize>504 x 720 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractWordCount>1</abstractWordCount><abstractCharCount>0</abstractCharCount><keywordCount>2</keywordCount></qualityIndicators><title>A cell culture assay for compounds which inhibit hepatitis B virus replication</title><pmid><json:string>1716089</json:string></pmid><pii><json:string>0166-3542(91)90068-3</json:string></pii><genre><json:string>research-article</json:string></genre><serie><title>Proc. Natl. Acad. Sci. USA</title><language><json:string>unknown</json:string></language><volume>84</volume><pages><first>4641</first><last>4644</last></pages></serie><host><title>Antiviral Research</title><language><json:string>unknown</json:string></language><publicationDate>1991</publicationDate><issn><json:string>0166-3542</json:string></issn><pii><json:string>S0166-3542(00)X0139-8</json:string></pii><volume>15</volume><issue>3</issue><pages><first>217</first><last>228</last></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>1000</json:string><json:string>1991</json:string></date><geogName></geogName><orgName><json:string>Hanna Biologics, Inc.</json:string><json:string>Oncor, Inc.</json:string><json:string>Division of Molecular Virology</json:string><json:string>Johns Hopkins University</json:string><json:string>Department of Immunology and Infectious Diseases</json:string><json:string>Life Technologies</json:string><json:string>ViraChem</json:string><json:string>Georgetown University</json:string><json:string>National Institutes of Allergy and Infectious Diseases</json:string><json:string>Molecular Diagnostic Systems, Inc.</json:string><json:string>Ambis Systems, Inc., San Diego</json:string><json:string>Sigma, Inc.</json:string><json:string>Gibco, Inc.</json:string><json:string>Burroughs Wellcome</json:string></orgName><orgName_funder><json:string>Burroughs Wellcome</json:string></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Korba</json:string><json:string>Unless</json:string><json:string>B.E. Korba</json:string><json:string>Gregory Milman</json:string></persName><placeName><json:string>Bristol</json:string><json:string>NY</json:string><json:string>Toxicity</json:string><json:string>Gaithersburg</json:string><json:string>MD</json:string><json:string>CA</json:string><json:string>Alameda</json:string><json:string>Grand Island</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Galibert et al., 1979</json:string><json:string>Price et al., 1989</json:string><json:string>Alexander and Williams, 1986</json:string><json:string>Gerin, 1984</json:string><json:string>Tabor, 1987</json:string><json:string>Tiollais et al., 1985</json:string><json:string>Sells et al., 1987</json:string><json:string>Shafritz and Rogler, 1984</json:string><json:string>Popper et al., 1986</json:string><json:string>Suzuki et al., 1988</json:string><json:string>Bronson et al., 1989</json:string><json:string>Sells et al., 1987, 1988</json:string><json:string>Beasley and Hwang, 1984</json:string><json:string>Seeger et al., 1986</json:string><json:string>Ueda et al., 1989</json:string><json:string>Korba et al., 1990</json:string><json:string>Nordenfelt et al., 1987</json:string><json:string>Acs et al., 1987</json:string><json:string>Korba et al., 1989</json:string><json:string>Thomas, 1987</json:string><json:string>Patki and Gupta, 1982</json:string><json:string>Tsurimoto et al., 1987</json:string><json:string>Summers and Mason, 1982</json:string><json:string>Galiberr et al., 1979</json:string><json:string>Balzarini et al., 1989</json:string><json:string>Lee et al., 1989</json:string><json:string>Sells et al., 1988</json:string><json:string>Sureau et al., 1986</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/6H6-KF2KH34H-W</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - virology</json:string><json:string>2 - pharmacology & pharmacy</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - biomedical research</json:string><json:string>3 - virology</json:string></scienceMetrix><scopus><json:string>1 - Life Sciences</json:string><json:string>2 - Immunology and Microbiology</json:string><json:string>3 - Virology</json:string><json:string>1 - Life Sciences</json:string><json:string>2 - Pharmacology, Toxicology and Pharmaceutics</json:string><json:string>3 - Pharmacology</json:string></scopus></categories><publicationDate>1991</publicationDate><copyrightDate>1991</copyrightDate><doi><json:string>10.1016/0166-3542(91)90068-3</json:string></doi><id>C7121E5E27952F43A3367A0914BD4F71F313AC72</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-KF2KH34H-W/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-KF2KH34H-W/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-KF2KH34H-W/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a">A cell culture assay for compounds which inhibit hepatitis B virus replication</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher><availability><licence><p>elsevier</p></licence></availability><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M"></p><date>1991</date></publicationStmt><notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">A cell culture assay for compounds which inhibit hepatitis B virus replication</title><author xml:id="author-0000"><persName><forename type="first">Brent E.</forename><surname>Korba</surname></persName><affiliation>Georgetown University, Division of Molecular Virology and Immunology, Rockville, Maryland, U.S.A.</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Gregory</forename><surname>Milman</surname></persName><affiliation>Department of Immunology and Infectious Diseases, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland, U.S.A.</affiliation></author><idno type="istex">C7121E5E27952F43A3367A0914BD4F71F313AC72</idno><idno type="ark">ark:/67375/6H6-KF2KH34H-W</idno><idno type="DOI">10.1016/0166-3542(91)90068-3</idno><idno type="PII">0166-3542(91)90068-3</idno></analytic><monogr><title level="j">Antiviral Research</title><title level="j" type="abbrev">AVR</title><idno type="pISSN">0166-3542</idno><idno type="PII">S0166-3542(00)X0139-8</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1991"></date><biblScope unit="volume">15</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="217">217</biblScope><biblScope unit="page" to="228">228</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1991</date></creation><langUsage><language ident="en">en</language></langUsage><textClass><keywords scheme="keyword"><list><head>Keywords</head><item><term>Cell culture assay</term></item><item><term>Hepatitis B virus</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1991">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-KF2KH34H-W/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="fla"><item-info><jid>AVR</jid><aid>91900683</aid><ce:pii>0166-3542(91)90068-3</ce:pii><ce:doi>10.1016/0166-3542(91)90068-3</ce:doi><ce:copyright type="unknown" year="1991"></ce:copyright></item-info><head><ce:title>A cell culture assay for compounds which inhibit hepatitis B virus replication</ce:title><ce:author-group><ce:author><ce:given-name>Brent E.</ce:given-name><ce:surname>Korba</ce:surname><ce:cross-ref refid="AFF1"><ce:sup>1</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Gregory</ce:given-name><ce:surname>Milman</ce:surname><ce:cross-ref refid="AFF2"><ce:sup>2</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="AFF1"><ce:label>a</ce:label><ce:textfn>Georgetown University, Division of Molecular Virology and Immunology, Rockville, Maryland, U.S.A.</ce:textfn></ce:affiliation><ce:affiliation id="AFF2"><ce:label>b</ce:label><ce:textfn>Department of Immunology and Infectious Diseases, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland, U.S.A.</ce:textfn></ce:affiliation></ce:author-group><ce:date-received day="24" month="7" year="1990"></ce:date-received><ce:date-accepted day="5" month="12" year="1990"></ce:date-accepted><ce:keywords><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>Cell culture assay</ce:text></ce:keyword><ce:keyword><ce:text>Hepatitis B virus</ce:text></ce:keyword></ce:keywords></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>A cell culture assay for compounds which inhibit hepatitis B virus replication</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>A cell culture assay for compounds which inhibit hepatitis B virus replication</title></titleInfo><name type="personal"><namePart type="given">Brent E.</namePart><namePart type="family">Korba</namePart><affiliation>Georgetown University, Division of Molecular Virology and Immunology, Rockville, Maryland, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Gregory</namePart><namePart type="family">Milman</namePart><affiliation>Department of Immunology and Infectious Diseases, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Full-length article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1991</dateIssued><copyrightDate encoding="w3cdtf">1991</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><subject><genre>Keywords</genre><topic>Cell culture assay</topic><topic>Hepatitis B virus</topic></subject><relatedItem type="host"><titleInfo><title>Antiviral Research</title></titleInfo><titleInfo type="abbreviated"><title>AVR</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1991</dateIssued></originInfo><identifier type="ISSN">0166-3542</identifier><identifier type="PII">S0166-3542(00)X0139-8</identifier><part><date>1991</date><detail type="volume"><number>15</number><caption>vol.</caption></detail><detail type="issue"><number>3</number><caption>no.</caption></detail><extent unit="issue-pages"><start>171</start><end>266</end></extent><extent unit="pages"><start>217</start><end>228</end></extent></part></relatedItem><identifier type="istex">C7121E5E27952F43A3367A0914BD4F71F313AC72</identifier><identifier type="ark">ark:/67375/6H6-KF2KH34H-W</identifier><identifier type="DOI">10.1016/0166-3542(91)90068-3</identifier><identifier type="PII">0166-3542(91)90068-3</identifier><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-KF2KH34H-W/record.json</uri></json:item></metadata></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001583 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001583 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:C7121E5E27952F43A3367A0914BD4F71F313AC72
|texte= A cell culture assay for compounds which inhibit hepatitis B virus replication
}}
| This area was generated with Dilib version V0.6.33. |  |